Last reviewed by Dr Sumit Mandal
Anaphylaxis kills by airway oedema, bronchospasm and distributive shock, sometimes all three in the same patient. Intramuscular adrenaline into the anterolateral thigh is the only intervention proven to reduce mortality; everything else is adjunctive.
Any one of three clinical patterns makes anaphylaxis highly likely. Do not wait for hypotension, skin plus airway, or skin plus breathing, is enough.
Five things, in this order. Adrenaline IM is the only drug that changes mortality. Antihistamines and steroids are adjuncts. They do not treat the airway or shock.
These are the recurring mistakes that turn a survivable anaphylaxis into a death. Each one delays or replaces IM adrenaline.
Defined as persistent symptoms after 2 appropriate IM doses. Move to an adrenaline infusion and call for senior airway and ICU support early.
Every patient gets a minimum observation period stratified by severity. Discharge is conditional on adrenaline auto-injector, written plan, and allergy follow-up.
The resuscitation is the easy half. What decides whether this patient survives the next exposure is a device they can use, a plan they can read, and a trigger they can name.
Two devices, because a single dose fails often enough that a second is standard, and because one gets lost or expires. Then the part that is routinely skipped: hand over the trainer and watch them do it. Into the outer thigh, through clothing if necessary, held in place, then massage the site. A prescription for a device the patient has never held is a piece of paper, not a treatment. Check the expiry date out loud and tell them to diarise it.
Adrenaline autoinjectors are expensive and inconsistently stocked across much of India, so a proportion of your patients will leave without one however good the prescription is. Say so honestly rather than pretending: document that the device was recommended and why it could not be obtained, and build the plan around what does exist, a written card naming the allergen, immediate transport to the nearest facility that stocks adrenaline, and knowing which that is before it is needed. Some families are taught to carry an ampoule and syringe with training; that is a decision for the allergy service, not a default from the ED.
One page, in the language the family actually reads: the named allergen, what the early symptoms look like, the instruction to use adrenaline FIRST rather than waiting to see, the position to lie in. Flat with legs raised, and never suddenly upright, because posture change has been associated with deterioration. Call for help, and a second dose after five minutes if there is no improvement. Give a copy to the patient and, for a child, to the school.
Most people labelled penicillin-allergic are not. The label follows them for life, pushes them onto worse antibiotics, and is associated with worse outcomes, and there is a validated bedside rule for sorting it.
A large majority of reported penicillin allergy does not survive formal testing. The common histories are childhood rashes during a viral illness that was being treated with an antibiotic, gastrointestinal upset, headache, or a family member's allergy transferred onto the patient. Ask three things: what happened, how long after the dose, and how long ago. Nausea and diarrhoea are intolerance, not allergy, and they belong in a different box on the chart.
A four-item clinical decision rule scores the reaction on whether it occurred within the last five years, whether it was anaphylaxis or angioedema, whether it was a severe cutaneous adverse reaction, and whether it required treatment. A very low score identifies patients at minimal risk in whom the label is very unlikely to be real. What that permits is a confident REFERRAL for de-labelling, not a challenge dose in the emergency department, which is not the place for it.
The traditional teaching of roughly ten percent cross-reactivity between penicillins and cephalosporins is far too high. Cross-reactivity tracks the similarity of the R1 side chain rather than the shared beta-lactam ring, so cephalosporins with dissimilar side chains carry very low risk. Practically: a remote, mild penicillin rash should not by itself deny a patient a cephalosporin when that is the right drug. But a documented anaphylaxis to any beta-lactam is a different conversation and needs specialist input.
Because the ED is where the label is most often acted on and least often examined. A wrong penicillin label pushes patients onto broader, more toxic and less effective alternatives, with more Clostridioides difficile and more resistant organisms, and it is associated with worse outcomes in serious infection. Two minutes of history in a patient who is not acutely allergic today, written clearly into the record, is a genuine intervention, and writing 'penicillin allergy: rash aged 6, no angioedema, tolerated cephalexin since' is worth more than the word allergy alone.
Clinical vignettes built from this chapter. Pass ≥70% to earn a printable 0.5 CME certificate.
Sign in to take the quiz and earn a certificate.
Print it, or send it on WhatsApp — the “While in the ED” sheets during the stay, the rest before the patient leaves. Choose Hindi, Hinglish or English on the next screen.
Discharge leaflet · 3 picturesGoing home after anaphylaxis — the next 72 hours, the next allergen-free year, the EpiPen reality in IndiaPrint / share →
Discharge leaflet · 3 picturesGoing home with hives (urticaria) — take the antihistamine every day until it settles, and know the swelling and breathing signs of a severe reactionPrint / share →
First aid at home · 3 picturesEpiPen / adrenaline auto-injector — through clothes, outer thigh, hold while you countPrint / share →Every clinical claim in this chapter is backed by an independent, freely-accessible guideline. Tap any reference to open the source on the issuing body's site.
Resuscitation Council UK 2025 — Emergency treatment of anaphylaxis: guidelines for healthcare providers
“Adrenaline should be given as soon as the diagnosis of anaphylaxis is suspected. The intramuscular route is recommended for most healthcare providers.”
Open source ↗
Anaphylaxis: assessment and referral after emergency treatment
Open source ↗
World Allergy Organization Anaphylaxis Guidance 2020
Open source ↗
European Resuscitation Council Guidelines 2025 — Cardiac Arrest in Special Circumstances (anaphylaxis)
Open source ↗
IAAA position statement on anaphylaxis recognition and adrenaline use
Open source ↗
EAACI guidelines: anaphylaxis — 2021 update
Open source ↗
Development and validation of a penicillin allergy clinical decision rule
Open source ↗
Cephalosporin side-chain cross-reactivity — the R-group basis for beta-lactam allergy risk
Open source ↗
Emergency treatment of anaphylaxis — Resuscitation Council UK guidance
Open source ↗
Compiled from contemporary emergency-medicine practice and the guidelines listed above. For registered medical practitioners; not a substitute for clinical judgement.
Study with Dr Sumit
Visual ED study chapters across resuscitation, trauma, cardiovascular, respiratory, neurology, toxicology, paediatrics and more, all built for working clinicians in Indian EDs and beyond. Plus calculators, decision rules, and clinical algorithms.
No clinical decisions should rest on a single source. Always cross-check with local protocols. Educational use only.